A Toolbox Approach to Obesity Treatment in Urban Safety-Net Primary Care Clinics: a Pragmatic Clinical Trial
Overview
Authors
Affiliations
Background: There is a need for new strategies to improve the success of obesity treatment within the primary care setting.
Objective: To determine if patients offered low out-of-pocket cost weight management tools achieved more weight loss compared to usual care.
Design: Twelve-month pragmatic clinical weight loss trial with a registry-based comparator group performed in primary care clinics of an urban safety-net hospital.
Participants: From a large clinical registry, we randomly selected 428 patients to have the opportunity to receive the intervention.
Interventions: Medical weight management tools-partial meal replacements, recreation center vouchers, pharmacotherapy, commercial weight loss program vouchers, and a group behavioral weight loss program-for $5 or $10 monthly. Patients chose their tools, could switch tools, and could add a second tool at 6 months.
Main Measures: The primary outcome was the proportion of intervention-eligible patients who achieved ≥ 5% weight loss. The main secondary outcome was the proportion of on-treatment patients who achieved ≥ 5% weight loss.
Key Results: Overall, 71.3% (305 of 428) had available weight measurement data/PCP visit data to observe the primary outcome. At 12 months, 23.3% (71 of 305) of intervention-eligible participants and 15.7% (415 of 2640) of registry-based comparators had achieved 5% weight loss (p < 0.001). Of the on-treatment participants, 34.5% (39 of 113) achieved 5% weight loss. Mean percentage weight loss was - 3.15% ± 6.41% for on-treatment participants and - 0.30% ± 6.10% for comparators (p < 0.001). The initially preferred tools were meal replacements, pharmacotherapy, and recreation center passes.
Conclusions: Access to a variety of low out-of-pocket cost weight management tools within primary care resulted in ≥ 5% body weight loss in approximately one quarter of low-income patients with obesity.
Trial Registration: https://clinicaltrials.gov/ct2/show/NCT01922934.
Kubesch N, Gaitonde S, Petriti U, Bakker E, Basu S, Birks L Clin Transl Sci. 2024; 17(11):e70072.
PMID: 39558508 PMC: 11573736. DOI: 10.1111/cts.70072.
Effects of Pharmacotherapy for the Treatment of Obesity in an Urban, Safety-Net Population.
Kim E, Hills N, Cheng Z, Tucker C, Gutierrez M, Alba D Cureus. 2023; 15(10):e47922.
PMID: 38034269 PMC: 10682737. DOI: 10.7759/cureus.47922.
McCarthy W, Rico M, Chandler M, Herman D, Chang C, Belin T Ann Fam Med. 2023; 21(3):213-219.
PMID: 37217336 PMC: 10202519. DOI: 10.1370/afm.2964.
Nederveld A, Phimphasone-Brady P, Connelly L, Fitzpatrick L, Holtrop J J Gen Intern Med. 2021; 36(9):2709-2716.
PMID: 33532954 PMC: 8390622. DOI: 10.1007/s11606-020-06548-w.